Velcade displays promising activity in primary effusion lymphoma cells

Cancer Biol Ther. 2005 Apr;4(4):491-2. doi: 10.4161/cbt.4.4.1645. Epub 2005 Apr 28.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Apoptosis / drug effects*
  • Boronic Acids / pharmacology*
  • Boronic Acids / therapeutic use
  • Bortezomib
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Humans
  • Lymphoma, B-Cell / drug therapy*
  • Lymphoma, B-Cell / genetics
  • Lymphoma, B-Cell / metabolism
  • Lymphoma, B-Cell / pathology
  • Pleural Effusion, Malignant / pathology*
  • Pyrazines / pharmacology*
  • Pyrazines / therapeutic use

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Bortezomib